News

* Researchers at the Danish Headache Center are testing semaglutide along with a very low calorie diet as a treatment for new ...
After Mikayla Nogueira unveiled her 60-pound weight loss transformation, the TikToker cleared the air on how she accomplished ...
While Ozempic is effective at treating type 2 diabetes and supporting weight loss, it can also come with side effects.
Shares in the maker of Ozempic crashed to three-year low after the pharma giant warned its injections were losing ground to ...
Drugmaker struggled to adapt to very high demand and a market where celebrities are more influential than doctors ...
The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, Wegovy®, and Mounjaro® has transformed obesity care and created an unexpected cosmetic challenge. Rapid fat loss can leave ...
Danish drugmaker Novo Nordisk's stock was down nearly 20% in premarket trading Tuesday morning after the company cut its ...
These semaglutide drugs became so popular after their efficacy for weight loss became apparent that, in a sense, they became ...
The Danish firm blamed the move to slash its guidance on intense competition from rivals and copycat drugs in the US.
Novo Nordisk’s plummet is a warning for backers who’ve crowded into a relatively small group of very large stocks.
A growing number of people are turning to medications like Ozempic, Wegovy, and Mounjaro to aid in weight loss and manage ...
Novo, which became Europe’s most valuable listed company following the launch of Wegovy in 2021, is now facing a reckoning as ...